NutriBand (NTRB) Enterprise Value Growth (3y) (2019 - 2026)
NutriBand (NTRB) Enterprise Value Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
NutriBand |
41.91 Mn |
37.33 Mn |
88,941.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
-32.08% |
| Oct 31, 2025 |
-23.56% |
| Jul 31, 2025 |
-27.88% |
| Apr 30, 2025 |
9.59% |
| Jan 31, 2025 |
4.12% |
| Oct 31, 2024 |
-1.28% |
| Jul 31, 2024 |
-181.13% |
| Apr 30, 2024 |
-172.90% |
| Jan 31, 2024 |
-48.02% |
| Oct 31, 2023 |
-87.03% |
| Jul 31, 2023 |
-290.36% |
| Apr 30, 2023 |
-295.60% |
| Jan 31, 2023 |
-479.90% |
| Oct 31, 2022 |
-206.86% |
| Jul 31, 2022 |
-522.98% |
| Apr 30, 2022 |
-170.85% |
| Jan 31, 2022 |
-117.62% |
| Oct 31, 2021 |
-177.19% |
| Jul 31, 2021 |
34.79% |
| Oct 31, 2020 |
-1,137.69% |
